← FDA Drug Approvals (Drugs@FDA)

LOTEMAX SM

NDA · New Drug Application · Sponsor: BAUSCH AND LOMB INC · Approved 2019-02-22

Drug application

FDA Application #

NDA208219

Application type

New Drug Application

Brand name

LOTEMAX SM

Generic name

LOTEPREDNOL ETABONATE

Active ingredients

LOTEPREDNOL ETABONATE

Dosage form

GEL

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

BAUSCH AND LOMB INC

Manufacturer

Bausch & Lomb Incorporated

First approval

2019-02-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown